tiprankstipranks
Trending News
More News >
Prostatype Genomics AB (DE:PGO0)
FRANKFURT:PGO0
Germany Market

Prostatype Genomics AB (PGO0) Ratios

Compare
1 Followers

Prostatype Genomics AB Ratios

DE:PGO0's free cash flow for Q2 2023 was kr-153.00. For the 2023 fiscal year, DE:PGO0's free cash flow was decreased by kr and operating cash flow was kr-180.61. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.27 1.06 3.27 6.29 4.05
Quick Ratio
3.26 1.05 3.26 6.26 3.96
Cash Ratio
1.11 0.11 1.11 2.87 3.68
Solvency Ratio
-5.66 -1.61 -5.66 -3.62 -3.21
Operating Cash Flow Ratio
-6.39 -1.19 -6.39 -4.69 -3.42
Short-Term Operating Cash Flow Coverage
-69.23 -2.51 -69.23 -40.20 -36.78
Net Current Asset Value
kr 9.37Mkr 1.36Mkr 9.37Mkr 17.29Mkr 12.08M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.24 0.03 0.03 0.04
Debt-to-Equity Ratio
0.03 0.47 0.03 0.04 0.05
Debt-to-Capital Ratio
0.03 0.32 0.03 0.03 0.05
Long-Term Debt-to-Capital Ratio
0.02 <0.01 0.02 0.02 0.04
Financial Leverage Ratio
1.18 1.99 1.18 1.12 1.19
Debt Service Coverage Ratio
-35.75 -2.89 -35.75 -31.80 -8.32
Interest Coverage Ratio
-72.41 -25.49 -72.41 -190.79 -11.12
Debt to Market Cap
<0.01 0.04 <0.01 <0.01 <0.01
Interest Debt Per Share
0.01 3.84 0.01 0.02 0.04
Net Debt to EBITDA
0.15 -0.24 0.15 0.55 0.91
Profitability Margins
Gross Profit Margin
-3675.84%274.93%-3675.84%25093.91%-2077.01%
EBIT Margin
-4201.83%-2942.11%-4201.83%-155467.10%-2327.00%
EBITDA Margin
-3922.97%-2803.83%-3922.97%-154582.36%-2305.20%
Operating Profit Margin
-4201.87%-2894.32%-4201.87%-155467.10%-2430.03%
Pretax Profit Margin
-4259.90%-3055.68%-4259.90%-156281.95%-2545.52%
Net Profit Margin
-4259.90%-3055.68%-4259.90%-156281.95%-2545.52%
Continuous Operations Profit Margin
-4259.97%-3055.68%-4259.97%-156281.95%-2545.52%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
101.38%105.57%101.38%100.52%104.75%
Return on Assets (ROA)
-93.98%-84.18%-93.98%-38.88%-51.71%
Return on Equity (ROE)
-111.23%-167.93%-111.23%-43.53%-61.53%
Return on Capital Employed (ROCE)
-107.79%-158.64%-107.79%-42.28%-56.61%
Return on Invested Capital (ROIC)
-112.31%-108.00%-112.31%-41.43%-55.85%
Return on Tangible Assets
-204.25%-159.11%-204.25%-72.36%-51.89%
Earnings Yield
-0.05%-13.44%-0.05%>-0.01%>-0.01%
Efficiency Ratios
Receivables Turnover
0.27 0.00 0.27 0.07 0.57
Payables Turnover
13.26 -0.25 13.26 -2.13 8.37
Inventory Turnover
588.61 -11.68 588.61 -23.25 37.70
Fixed Asset Turnover
189.72 22.60 189.72 0.71 24.23
Asset Turnover
0.02 0.03 0.02 <0.01 0.02
Working Capital Turnover Ratio
0.05 0.24 0.05 <0.01 0.00
Cash Conversion Cycle
1.31K 1.42K 1.31K 5.51K 606.25
Days of Sales Outstanding
1.34K 0.00 1.34K 5.35K 640.18
Days of Inventory Outstanding
0.62 -31.24 0.62 -15.70 9.68
Days of Payables Outstanding
27.52 -1.45K 27.52 -171.53 43.61
Operating Cycle
1.34K -31.24 1.34K 5.33K 649.86
Cash Flow Ratios
Operating Cash Flow Per Share
-0.31 -8.47 -0.31 -0.23 -0.21
Free Cash Flow Per Share
-0.31 -10.95 -0.31 -0.27 -0.26
CapEx Per Share
0.00 2.49 0.00 0.04 0.05
Free Cash Flow to Operating Cash Flow
1.00 1.29 1.00 1.16 1.22
Dividend Paid and CapEx Coverage Ratio
0.00 -3.40 0.00 -6.43 -4.52
Capital Expenditure Coverage Ratio
0.00 -3.40 0.00 -6.43 -4.52
Operating Cash Flow Coverage Ratio
-31.95 -2.50 -31.95 -12.69 -10.03
Operating Cash Flow to Sales Ratio
-40.56 -21.49 -40.56 -1.61K -21.51
Free Cash Flow Yield
-0.04%-12.23%-0.04%>-0.01%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.14K -7.44 -2.14K -13.12K -18.85K
Price-to-Sales (P/S) Ratio
91.30K 227.40 91.30K 20.50M 479.89K
Price-to-Book (P/B) Ratio
2.38K 12.50 2.38K 5.71K 11.60K
Price-to-Free Cash Flow (P/FCF) Ratio
-2.25K -8.18 -2.25K -11.04K -18.26K
Price-to-Operating Cash Flow Ratio
-2.25K -10.58 -2.25K -12.75K -22.31K
Price-to-Earnings Growth (PEG) Ratio
-49.30 1.70 -49.30 1.64K 0.00
Price-to-Fair Value
2.38K 12.50 2.38K 5.71K 11.60K
Enterprise Value Multiple
-2.33K -8.35 -2.33K -13.26K -20.82K
Enterprise Value
62.34B 317.33M 62.34B 205.04B 328.17B
EV to EBITDA
-2.33K -8.35 -2.33K -13.26K -20.82K
EV to Sales
91.30K 234.02 91.30K 20.50M 479.87K
EV to Free Cash Flow
-2.25K -8.42 -2.25K -11.04K -18.26K
EV to Operating Cash Flow
-2.25K -10.89 -2.25K -12.75K -22.31K
Tangible Book Value Per Share
0.11 0.43 0.11 0.25 0.41
Shareholders’ Equity Per Share
0.30 7.17 0.30 0.52 0.41
Tax and Other Ratios
Effective Tax Rate
-0.06 0.00 -0.06 <0.01 <0.01
Revenue Per Share
<0.01 0.39 <0.01 <0.01 <0.01
Net Income Per Share
-0.33 -12.04 -0.33 -0.23 -0.25
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.01 1.04 1.01 1.01 1.09
Research & Development to Revenue
5.14 2.38 5.14 148.80 3.53
SG&A to Revenue
19.76 0.00 19.76 849.02 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.95 0.70 0.95 1.03 0.85
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis